Tango Therapeutics

Tango Therapeutics

Tango Therapeutics

Tango Therapeutics is a biotechnology company developing novel medicines
Suggest edits
Type
B2c
Founded
2017
Raised
$115M
Follow us
Companies in the same industry
Alexa global traffic share
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2

Add info
Add round
12 Apr 2020
$60,000,000
Venture capital (Series B)
Casdin Capital, Cormorant Asset Management, Boxer Capital

Targeted Cancer Therapies Company Tango Closes $60 Million

Pulse 2.0
30 Mar 2017
$55,000,000
Venture capital (Series A)
Third Rock Ventures

Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment

businesswire